PropertyValue
?:abstract
  • Here, we provide an extensive overview of all reported COVID-19 cases in multiple sclerosis (MS) patients in the Netherlands between 27 February and 9 June 2020, gathered by the Dutch MS Taskforce of the Netherlands Society of Neurology. A total of 86 MS patients were reported, 43 of whom tested positive for COVID-19. Of 43 patients who tested positive, 22 patients were hospitalized. Three intensive care unit (ICU) admissions and four deaths were reported. Our findings show no apparent difference in disease-modifying treatment (DMT) use and COVID-19 disease course in Dutch MS patients. In addition, a clear link between low lymphocyte count and severe disease was not observed.
?:creator
?:doi
  • 10.1177/1352458520942198
?:doi
?:journal
  • Mult_Scler
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/6b702fa10d087f9fc874ee4a4600690ebc109fca.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7493197.xml.json
?:pmcid
?:pmid
?:pmid
  • 32662742.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19 in multiple sclerosis: The Dutch experience
?:type
?:year
  • 2020-07-14

Metadata

Anon_0  
expand all